Yahoo
Stockholm - Delayed Quote SEK

BrainCool AB (publ) (BRAIN.ST)

1.0400 +0.0080 (+0.78%)
At close: October 30 at 12:59:43 PM GMT+1
Chart Range Bar
Loading chart for BRAIN.ST
  • Previous Close 1.0320
  • Open 1.0200
  • Bid 0.9810 x --
  • Ask 1.0400 x --
  • Day's Range 0.9700 - 1.0400
  • 52 Week Range 0.4105 - 1.1500
  • Volume 192,270
  • Avg. Volume 437,325
  • Market Cap (intraday) 410.673M
  • Beta (5Y Monthly) 1.34
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1100
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 1.00

BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powered cooling product to spray liquid coolant for patient's nostrils with a catheter; Cooral system provides medical professionals a way to reduce the risk of oral mucositis; and IQool system, a temperature management system that monitors and controls a patient's temperature. In addition, the company provides products for medical cooling treatments for diseases, such as stroke, cardiac arrest, migraine, and oral mucositis. BrainCool AB (publ) was incorporated in 2010 and is based in Lund, Sweden.

braincoolinc.com

15

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

BRAIN.ST
75.68%
OMX Stockholm 30 Index (^OMX)
13.47%

1-Year Return

BRAIN.ST
72.76%
OMX Stockholm 30 Index (^OMX)
17.56%

3-Year Return

BRAIN.ST
76.89%
OMX Stockholm 30 Index (^OMX)
59.03%

5-Year Return

BRAIN.ST
84.91%
OMX Stockholm 30 Index (^OMX)
42.80%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 11.33M
Earnings --
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-5M
0
5M
10M
-150.0%
-100.0%
-50.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

1.00 Low
1.00 Average
1.0400 Current
1.00

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -74.07%

  • Return on Assets (ttm)

    -12.89%

  • Return on Equity (ttm)

    -24.11%

  • Revenue (ttm)

    46.49M

  • Net Income Avi to Common (ttm)

    -34.43M

  • Diluted EPS (ttm)

    -0.1100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    43.09M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -7.63M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: